Related Experiment Video
Updated: Apr 29, 2026

Knee Arthrocentesis in Adults
Published on: February 25, 2022
Intravenous golimumab in rheumatoid arthritis
Marc D Cohen1, Edward C Keystone
1Mayo Clinic, 668 Humboldt St, Denver, CO 80218, USA.
Abstract:
Intravenous golimumab in a dosage of 2 mg/kg, initially given every 4 weeks but then every 8 weeks, in addition to methotrexate, is effective in the treatment of patients with rheumatoid arthritis. This weight-based infusion is administered over thirty minutes with an acceptable safety profile. Since it is a relatively new formulation, more time will be required to assess its specific role in the rheumatologists' armamentarium and to appreciate more fully its long-term safety.
More Related Videos
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Rheumatic Heart Disease III: Medical Management
Drugs for Treatment of Ulcerative Colitis in IBD
Rheumatic Heart Disease IV: Nursing Management

